The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.3051
https://www.valueinhealthjournal.com/article/S1098-3015(17)33386-7/fulltext
Title :
The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33386-7&doi=10.1016/j.jval.2017.08.3051
First page :
A666
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
1454